Digestive Diseases and Sciences

, Volume 52, Issue 10, pp 2821–2825 | Cite as

Helicobacter pylori Infection and Severity of Reflux-Induced Esophageal Disease in a Cohort of Patients with Columnar-Lined Esophagus

  • James R. Ramus
  • Piers A. C. Gatenby
  • Christine P. J. Caygill
  • Anthony Watson
Original Paper

Abstract

The relationship between Helicobacter pylori infection and reflux-induced esophageal diseased is controversial. We examined esophageal disease severity in patients with columnar-lined esophagus and compared results between patients with and without Helicobacter pylori infection. Medical records of 1000 patients diagnosed with columnar-lined esophagus were examined. Endoscopic and histological findings of reflux-induced esophageal disease were compared between H. pylori-positive and H. pylori-negative patients. Four hundred twenty-nine patients (42.9%) showed evidence of H. pylori status, of whom 239 (55.7%) were positive and 190 (44.3%) negative. There were no significant differences in length of columnar-lined segment (= 0.305), frequency of associated esophagitis (= 0.583), or presence of gastroduodenal inflammation (= 0.335, = 0.131) between the two groups. Histological grade of esophageal disease severity was similar between them, with no statistically significant differences (= 0.231).

We conclude that in patients with established columnar-lined esophagus, there appears to be no difference in severity of reflux-induced esophageal disease between those with and those without H. pylori infection.

Keywords

Esophagus Barrett’s Helicobacter pylori Dysplasia Eradication 

References

  1. 1.
    Lee JM, O’Morain CA (1998) Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? Gut 43(Suppl 1):S14–S20PubMedCrossRefGoogle Scholar
  2. 2.
    Fink SM et al. (1984) The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying. J Clin Gastroenterol 6:301–309PubMedGoogle Scholar
  3. 3.
    Vicari J, Falk GW, Richter JE (1997) Helicobacter pylori and acid peptic disorders of the esophagus: is it conceivable? Am J Gastroenterol 92:1097–1102PubMedGoogle Scholar
  4. 4.
    Boyd EJ (1996) The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol 91:1539–1543PubMedGoogle Scholar
  5. 5.
    Labenz J, Malfertheiner P (1997) Helicobacter pylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor? Gut 41:277–280PubMedCrossRefGoogle Scholar
  6. 6.
    Hirschl AM, Schulze K, Hentsche E (1989) Serological, microbiological and clinical results of a 43 months follow-up after successful eradication of H. pylori in duodenal ulcer disease. Am J Gastroenterol 89:1374Google Scholar
  7. 7.
    Rauws EA, Tytgat GN (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335:1233–1235PubMedCrossRefGoogle Scholar
  8. 8.
    Parsonnet J, et al. (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMedCrossRefGoogle Scholar
  9. 9.
    Axon A, Forman D (1997) Helicobacter gastroduodenitis: a serious infectious disease. BMJ 314:1430–431PubMedGoogle Scholar
  10. 10.
    Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ (1994) Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 120:977–981PubMedGoogle Scholar
  11. 11.
    Uemura N, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789PubMedCrossRefGoogle Scholar
  12. 12.
    Richter JE (2001) H pylori: the bug is not all bad. Gut 49:319–320PubMedGoogle Scholar
  13. 13.
    Blaser MJ (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523–1530PubMedCrossRefGoogle Scholar
  14. 14.
    Sehiguchi T, Shirota T, Horikoshi T (1996) Helicobacter pylori infection and severity of reflux oesophagitis. Gastroenterology 110:A755Google Scholar
  15. 15.
    Grebenev AL (1994) Helicobacter pylori (Hp) and reflux oesophagitis. Gastroenterology 89:A1372Google Scholar
  16. 16.
    Labenz J, et al. (1997) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112:1442–1447PubMedCrossRefGoogle Scholar
  17. 17.
    Levi S, et al. (1989) Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1:1167–1168PubMedCrossRefGoogle Scholar
  18. 18.
    Smith JT, et al. (1990) Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 31:522–525PubMedGoogle Scholar
  19. 19.
    el Omar EM, et al. (1995) Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109:681–691PubMedCrossRefGoogle Scholar
  20. 20.
    Sharma VK, Demian SE, Taillon D, Vasudeva R, Howden CW (1999) Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus. Dig Dis Sci 44:1165–1168PubMedCrossRefGoogle Scholar
  21. 21.
    Caygill CP, et al. (2002) Lifestyle factors and Barrett’s esophagus. Am J Gastroenterol 97:1328–1331PubMedCrossRefGoogle Scholar
  22. 22.
    Rugge M, et al. (2001) The phenotype of gastric mucosa coexisting with Barrett’s oesophagus. J Clin Pathol 54:456–460PubMedCrossRefGoogle Scholar
  23. 23.
    Oberg S, et al. (1999) Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg 134:722–726PubMedCrossRefGoogle Scholar
  24. 24.
    Newton M, Bryan R, Burnham WR, Kamm MA (1997) Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett’s oesophagus. Gut 40:9–13PubMedGoogle Scholar
  25. 25.
    Henihan RD, et al. (1998) Barrett’s esophagus and the presence of Helicobacter pylori. Am J Gastroenterol 93:542–546PubMedCrossRefGoogle Scholar
  26. 26.
    Loffeld RJ, Ten Tije BJ, Arends JW (1992) Prevalence and significance of Helicobacter pylori in patients with Barrett’s esophagus. Am J Gastroenterol 87:1598–1600PubMedGoogle Scholar
  27. 27.
    Hackelsberger A, et al. (1998) The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 10:465–468PubMedCrossRefGoogle Scholar
  28. 28.
    Grimley CE, Holder RL, Loft DE, et al. (1999) Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastro Hepatol 11:503–509CrossRefGoogle Scholar
  29. 29.
    Verdu EF, et al. (1995) Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 36:539–543PubMedGoogle Scholar
  30. 30.
    Labenz J, et al. (1996) Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110:725–732PubMedCrossRefGoogle Scholar
  31. 31.
    Kuipers EJ, et al. (1996) Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334:1018–1022PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • James R. Ramus
    • 1
    • 2
  • Piers A. C. Gatenby
    • 1
  • Christine P. J. Caygill
    • 1
  • Anthony Watson
    • 1
  1. 1.UK National Barrett’s Esophagus RegistryUniversity Department of SurgeryLondonUK
  2. 2.BucksUK

Personalised recommendations